-
Mashup Score: 1Genotype–phenotype landscapes for immune–pathogen coevolution - 2 year(s) ago
Our adaptive immune systems are engaged in a continuous coevolutionary struggle with the pathogens that attack us [1,2]. This immune–pathogen coevolution takes place across a range of spatial and temporal scales: evolution in individual infections is driven by interactions between pathogens and an individual host immune system, often over the course of days or weeks, while global pathogen…
Source: Trends in ImmunologyCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0COVID-19: Study Suggests Long-term Damage to Immune System - 2 year(s) ago
NIH News Release: “…findings suggest that SARS-CoV-2 infection damages the CD8+ T cell response, an effect akin to that observed in earlier studies showing long-term damage to the immune system after infection with viruses such as hepatitis C or HIV.”
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
"We are entering a phase of long COVID and chronic disability." https://t.co/40aKBoFtr3 #COVID-19 #immune system #CD8+Tcells @NIH
-
-
Mashup Score: 0COVID-19: Study Suggests Long-term Damage to Immune System - 2 year(s) ago
NIH News Release: “…findings suggest that SARS-CoV-2 infection damages the CD8+ T cell response, an effect akin to that observed in earlier studies showing long-term damage to the immune system after infection with viruses such as hepatitis C or HIV.”
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Several studies "findings suggest that SARS-CoV-2 infection damages the CD8+ T cell response..." --NIH https://t.co/eZrSOg8qTD #COVID-19 #immune system #CD8+Tcells @NIH
-
-
Mashup Score: 0Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients - 2 year(s) ago
AbstractAims. Chimeric antigen receptor T-cell therapy (CAR-T) harnesses a patient’s immune system to target cancer. There are sparse existing data characterizi
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Chimeric antigen receptor T-cell therapy harnesses patient’s immune system to target cancer. Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients. #biomarkers #immune #cardiotwitter @ESC_Journals @escardio https://t.co/ahRTfbm7zG https://t.co/1w24o79lhC
-
-
Mashup Score: 4
PD-1 and PD-L1 together constitute the stimulus signaling pathway of adaptive immune response, which has been widely used in the research on the mechanism of tumor immune escape and tumor therapy. At the same time, its signaling pathway has been proved to be closely associated with the immune escape of hepatic echinococcosis. This article reviews the chemical structures of PD-1 and PD-L1, the…
Source: www.lcgdbzz.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
Immune escape of hepatic echinococcosis based on the PD-1/PD-L1 signaling pathway #some4surgery #sminaev #hydatidcyst #hepatic #liver #immune https://t.co/H60g9Iw8W9
-
-
Mashup Score: 1
Cedars-Sinai, 4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today, 3/18/2023 7:30:00 AM – 3/18/2023 2:00:00 PM, The fourth annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been…
Source: cedars.cloud-cme.comCategories: Hem/Oncs, Latest HeadlinesTweet-
@GIcancerDoc @MayoClinic how to enhance systemic cures w/#IO in MSI-H #mCRC and bring #Chalabi plot results to non-met #crcsm and ongoing efforts to crack the #immune cold nature of #MSS mCRC @CSCancerCenter 4th Annual GI Tumor conf https://t.co/7s8rEqg0r4 @OncoAlert https://t.co/AxfAoH25Rx
-
-
Mashup Score: 9Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing - Nature Communications - 2 year(s) ago
It is essential to understand heterogeneity and evolution at different omics levels in oesophageal squamous cell carcinoma (ESCC). Here, the authors use multi-omics to analyse heterogeneity and evolution in ESCC patient samples, and characterise the levels of immune infiltration as well as selective pressure from the tumour microenvironment.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
#MultiOmics analysis of #EsophagealCancer characterises #heterogeneity, #evolution, #immune infiltration across sites, and selective pressure from the tumour #microenvironment #CancerResearch @natrescancer https://t.co/QuGC704GcA https://t.co/n2rdZ3xygd
-
-
Mashup Score: 1
Immune-related adverse events (irAEs) are frequently reported during immune checkpoint inhibitor (ICI) therapy and are associated with long-term outcomes. It is unknown if the irAE occurrence is a valid surrogate of ICIs’ efficacy.
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet-
#Immune-related adverse events as potential surrogates of immune #checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies. Please visit @ESMO_Open by @myESMO https://t.co/ItdMpp2N6p
-
-
Mashup Score: 0NextMed Health - 2 year(s) ago
NextMed Health is an innovation platform catalyzing the future of health and medicine. From the founder and team behind Exponential Medicine, NextMed brings together the global ecosystem of technology & healthcare innovators through summits, community & collaboration at the convergence of A
Source: NextMed HealthCategories: Future of Medicine, Latest HeadlinesTweet-
.@drhanskeirstead, CEO of @ImmunisInc and @janemetcalfe, Founder of @NEOdotLIFEand co-founder of @WIRED, will be joining us to talk about regenerative #medicine and #immune #engineering! https://t.co/xRGSmePnDv #regenerativemedicine #technology #innovation #healthcare #health https://t.co/rLv2CXWeBa
-
-
Mashup Score: 0
Scientists are deciphering how the brain choreographs immune responses, hoping to find treatments for a range of diseases.
Source: www.nature.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
🧠🔥Your #brain could be controlling how sick you get — and how you recover @Nature Scientists are deciphering how the brain choreographs #immune responses, hoping to find #treatments for a range of #diseases. #science #research @EvanKirstel https://t.co/IjcxfmsMbw… https://t.co/5WvNQwEcC0
-
Pathogens are constantly evolving, challenging our #immune systems to keep up. 🦠🏃 Published in @TrendsImmuno, the following review highlights exciting developments in high-throughput methods for studying immune-pathogen coevolution. Learn more: 🔗 https://t.co/DTBVOJHoX9 https://t.co/j7rpYo97ZS